Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Novo Nordisk A/S (NVO) vs Pure Storage (P) Price & Performance

Novo Nordisk A/STrade
Pure StorageTrade

Price performance (Past 24H)

Key statistics

Novo Nordisk A/S vs Pure Storage — how do they compare? Novo Nordisk A/S trades at $44.73 (market cap $200.69B), while Pure Storage trades at $98.27 (market cap $33.70B). The key difference: Novo Nordisk A/S is far larger — about 6× Pure Storage's market cap, and Novo Nordisk A/S pays a 3.98% dividend while Pure Storage pays none. Which is the better fit depends on your goals.

NVOP
Market Cap
$200.69B$33.70B
Sector
HealthTechnology
52-Week High
$63.98$118.16
52-Week Low
$35.29$56.99
Enterprise Value
$215.49B$32.92B
Dividend Yield
3.98%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Novo Nordisk A/S

Novo Nordisk (NVO) trades at $45.16, down 3.09% today, with bearish technical signals but strong fundamentals. The stock shows robust profitability with 35.35% net margin and 59.82% ROE, supported by consistent earnings beats. Recent developments include positive pediatric obesity trial results for semaglutide and Wegovy pill launch in Germany. Cash flow remains healthy with $10.81B net inflow in 2025, though 2026 projections show a decline.

NVO presents a mixed outlook with strong fundamental metrics offset by technical weakness and competitive pressures. Investment opportunity lies in the expanding GLP-1 market and pipeline developments, while risks include market share loss to Eli Lilly and failed cardiovascular drug trials. Analyst consensus leans bullish with 57.9% buy ratings, but recent prescription slowdown concerns warrant caution.

Pure Storage

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Novo Nordisk A/S

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Read more on NVO

About Pure Storage

Pure Storage develops enterprise data storage and data management systems, primarily using all-flash technology. Its platform supports cloud, AI, analytics, and mission-critical application workloads.

Read more on P